Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
The US investigation is still ongoing, however, and has been broadened to include Lillys dual GLP-1/GIP agonist tirzepatide, approved as Mounjaro for obesity and Zepbound for obesity
But even with that long list of upsides, theres still one pesky side effect many struggle with while taking a GLP-1: muscle loss
John Bacha, specializing in bariatric surgery, offers expert guidance and personal insights to help patients achieve their weight loss goals
This step allows us to establish a baseline for your overall health and determine if youre a suitable candidate for treatment
However, if youre not achieving the desired weight loss, or youre experiencing intolerable side effects, your treatment may need to be adjusted or discontinued
